NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 3 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Michela Tinelli M; Aine Roddy; Martin Knapp; Celso Arango; Maria Andreina Mendez; James Cusack; Declan Murphy; Roberto Canitano; Bethany Oakley; Vinciane Quoidbach – Journal of Autism and Developmental Disorders, 2024
We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children's families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For…
Descriptors: Foreign Countries, Autism Spectrum Disorders, Epilepsy, Pharmacology
Peer reviewed Peer reviewed
Direct linkDirect link
Alejandro Cano Villagrasa; Nadia Porcar Gozalbo; Beatriz Valles González; Miguel López-Zamora – Journal of Autism and Developmental Disorders, 2025
Autism Spectrum Disorder (ASD) and epilepsy represent a comorbidity that negatively influences the proper development of linguistic competencies, particularly in receptive language, in the pediatric population. This group displays impairments in the auditory comprehension of both simple and complex grammatical structures, significantly limiting…
Descriptors: Autism Spectrum Disorders, Epilepsy, Comorbidity, Language Proficiency
Peer reviewed Peer reviewed
Direct linkDirect link
Folch, Annabel; Salvador-Carulla, Luis; Vicens, Paloma; Cortés, Maria José; Irazábal, Marcia; Muñoz, Silvia; Rovira, Lluís; Orejuela, Carmen; González, Juan A.; Martínez-Leal, Rafael – Journal of Applied Research in Intellectual Disabilities, 2019
Background: The aim of this paper was to summarize the main results of the POMONA-ESP project, the first study to explore health status in a large representative, randomized and stratified sample of people with intellectual developmental disorders in Spain. Methods: The POMONA-ESP project collected information about the health of 953 individuals…
Descriptors: Health, Intellectual Disability, Health Services, Drug Therapy